Srinag Pharma Private Limited
About Srinag Pharma Private Limited
Data last updated:
Srinag Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2017PTC119111. Its GSTIN is 36AAZCS1341J1ZV (Telangana).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹23.38 Lakh. It is led by directors including Srinivasulu Chowdary Kavuturu (Managing Director) and Pinnenti Nageswara Rao.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F.No:507 7 – 2 – 1813/5 S.V.S.S. Nivas South Wing Czech Colony, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.43 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹33.12 Lakh (net margin 7.5%) and EBITDA of ₹47.75 Lakh (EBITDA margin 10.8%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹9.8 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Srinag Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressF.No:507 7 – 2 – 1813/5 S.V.S.S. Nivas South Wing Czech Colony, Hyderabad, Telangana, India – 500018
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Srinag Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Srinag Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Srinag Pharma Private Limited, buy the company report.
Financials of Srinag Pharma Private Limited
FY 2025 filings availableSrinag Pharma Private Limited reported revenue of ₹4.43 Cr (up 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 24% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹47.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33.12 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.8% | ||||
| Net Profit Margin | 7.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Srinag Pharma Private Limited, buy the company report.
Board of directors of Srinag Pharma Private Limited
Srinag Pharma has 7 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasulu Chowdary Kavuturu Also directs: Vitex Laboratories Private Limited, SVR Drugs Private Limited, S.V.R. Laboratories Private Limited and 1 more | Managing Director | 25 Aug 2017 | 9 Years 2 Months | Current |
| Pinnenti Nageswara Rao Also directs: SVR Drugs Private Limited, S.V.R. Laboratories Private Limited | Director | 25 Aug 2017 | 9 Years 2 Months | Current |
| Syam Kumar Kokku Also directs: Bhasya International Private Limited | Director | 28 Dec 2024 | 1 Years 9 Months | Current |
| Bhaskara Rao Akkapolu Also directs: Bhasya International Private Limited | Director | 06 Jun 2025 | 1 Years 4 Months | Current |
| Veera Basava Shivakumari Samatham Also directs: Bhasya International Private Limited | Director | 06 Jun 2025 | 1 Years 4 Months | Current |
| Kavuturu Harshavardhan Also directs: Azakem Labs Private Limited | Director | 05 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Srinag Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kowentush Medlabs Private Limited | ₹4.43 Cr (FY 2025) | -8.0% | Mahendru, Bihar, India | |||
| Lifegrace Pharmaceuticals Private Limited | ₹4.43 Cr (FY 2025) | 25.0% | Delhi, India | |||
| Huida Sanitaryware India Private Limited | ₹4.43 Cr (FY 2024) | 1687.0% | Bangalore, Karnataka, India | |||
| Skysun Lifesciences Private Limited | ₹4.43 Cr (FY 2024) | 29.0% | Ahmedabad, Gujarat, India | |||
| Samco Textile Private Limited | ₹4.43 Cr (FY 2024) | -23.0% | Howrah, West Bengal, India | |||
| Srinag Pharma Private Limitedthis company | ₹4.43 Cr (FY 2024) | ₹33.12 Lakh | 7.5% | 24.0% | Hyderabad, Telangana, India | |
| Binu Creations Pvt Ltd | ₹4.43 Cr (FY 2025) | -58.0% | Kolkata, West Bengal, India | |||
| Spiral Product Design Private Limited | ₹4.43 Cr (FY 2025) | 18.0% | New Delhi, Delhi, India | |||
| LKS Home Making Solution Private Limited | ₹4.42 Cr (FY 2025) | 14.0% | New Delhi, Delhi, India | |||
| Desmil Fashions Private Limited | ₹4.42 Cr (FY 2025) | 24.0% | Jalandhar, Punjab, India | |||
| Veriyog International Private Limited | ₹4.42 Cr (FY 2025) | 19.0% | Surat, Gujarat, India |
To see the full peer comparison of Srinag Pharma Private Limited, buy the company report.
Auditor
Srinag Pharma Private Limited is audited by VASANTHA RAO & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VASANTHA RAO & ASSOCIATES | FY 2021 | 004548S |
Shareholding
The shareholding of Srinag Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Srinag Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Feb 2025 | 101063806 | Others | ₹9.8 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Srinag Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Srinag Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Srinag Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAZCS1341J1ZV | Telangana | Active | 26 Sep 2017 |
To see the full GST registrations and return filing status of Srinag Pharma Private Limited, buy the company report.
Recent activity
Srinag Pharma Private Limited has 11 board changes on record since 2017: 9 appointments and 2 cessations. The latest: Bhaskara Rao Akkapolu was appointed as Director on 06 Jun 2025.
3 earlier events are in the company report.
Frequently asked questions
Srinag Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 August 2017 (9+ years old) and is registered under CIN U24299TG2017PTC119111.
Srinag Pharma has 7 current directors:
- Srinivasulu Chowdary Kavuturu - Managing Director
- Pinnenti Nageswara Rao - Director
- Syam Kumar Kokku - Director
- Bhaskara Rao Akkapolu - Director
- Veera Basava Shivakumari Samatham - Director
- Kavuturu Harshavardhan - Director
- Manoj Sai Pinnenti - Director
The latest financial statements of Srinag Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Srinag Pharma is 36AAZCS1341J1ZV, registered in Telangana.
The CIN (Corporate Identification Number) of Srinag Pharma is U24299TG2017PTC119111. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srinag Pharma was incorporated on 25 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Srinag Pharma by revenue are Kowentush Medlabs Private Limited, Lifegrace Pharmaceuticals Private Limited, Huida Sanitaryware India Private Limited, Skysun Lifesciences Private Limited, Samco Textile Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Bhaskara Rao Akkapolu was appointed as Director on 06 Jun 2025. Veera Basava Shivakumari Samatham was appointed as Director on 06 Jun 2025. Kavuturu Harshavardhan was appointed as Director on 05 Feb 2025. Srinag Pharma has 11 board changes on record in total.
The registered office of Srinag Pharma is at F.No:507 7 – 2 – 18135 S.V.S.S. Nivas South Wing Czech Colony, Hyderabad, Telangana, India – 500018.
Srinag Pharma operates in the pharma industry, in the drug formulation and development segment.
Srinag Pharma has open charges of ₹9.8 Cr and no satisfied charges on record as per latest MCA filings.